Sun Pharma to acquire Organon's India business in $12B deal

28 Apr 2026via The Economic TimesSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Sun Pharma to acquire Organon's India business in $12B deal — This landmark $12 billion transaction marks one of the largest in India’s pharma sector. The deal will significantly expand Sun Pharma’s portfolio and market reach. It includes Organon’s women’s health and specialty brands. The acquisition is expected to close by 2025 pending regulatory approvals.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Mergers

#Mergers#SunPharma#Organon

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →